Vontobel Holding Ltd. Acquires 20,500 Shares of Heartflow, Inc. $HTFL

Key Points

• Vontobel Holding initiated a Heartflow position by purchasing 20,500 shares worth approximately $1.02 million in the third quarter. Several other institutional investors also added or initiated stakes.
• Heartflow reported quarterly revenue of $64.08 million, up 47.7% year over year, and an adjusted loss of $0.07 per share—better than the $0.22 consensus estimate. Despite strong growth, the company remains unprofitable, with a negative net margin of 55.82%.
• HTFL traded at $51.02, near its 52-week high, while analysts maintained a generally positive view with a “Moderate Buy” consensus and an average price target of $46.25. Insiders, however, sold 304,105 shares worth about $14.2 million over the past three months.

Vontobel Holding Ltd. bought a new position in shares of Heartflow, Inc. (NASDAQ:HTFL - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 20,500 shares of the company's stock, valued at approximately $1,020,000.

Other large investors also recently bought and sold shares of the company. Avior Wealth Management LLC increased its position in shares of Heartflow by 16.1% in the third quarter. Avior Wealth Management LLC now owns 14,553 shares of the company's stock valued at $724,000 after buying an additional 2,023 shares in the last quarter. Capital Advisors Wealth Management LLC purchased a new stake in shares of Heartflow in the 3rd quarter worth about $224,000. GAMMA Investing LLC boosted its position in shares of Heartflow by 75.1% in the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company's stock worth $32,000 after buying an additional 275 shares in the last quarter. Valeo Financial Advisors LLC acquired a new stake in Heartflow in the 3rd quarter valued at about $213,000. Finally, Engineers Gate Manager LP acquired a new stake in Heartflow in the 2nd quarter valued at about $590,000.

Heartflow Price Performance

NASDAQ:HTFL opened at $51.02 on Tuesday. The firm has a 50 day simple moving average of $47.70 and a 200-day simple moving average of $35.53. The firm has a market cap of $4.44 billion, a PE ratio of -27.88 and a beta of 2.73. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $54.32.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. Heartflow's revenue for the quarter was up 47.7% compared to the same quarter last year. As a group, sell-side analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insider Buying and Selling at Heartflow

In other Heartflow news, insider Campbell Rogers sold 19,682 shares of the stock in a transaction on Friday, September 18th. The stock was sold at an average price of $50.15, for a total transaction of $987,052.30. Following the transaction, the insider owned 79,956 shares of the company's stock, valued at $4,009,793.40. This represents a 19.75% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Vikram Verghese sold 29,714 shares of the firm's stock in a transaction on Friday, September 11th. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84. Following the sale, the chief financial officer owned 184,789 shares in the company, valued at $9,250,537.34. This trade represents a 13.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 304,105 shares of company stock worth $14,173,800. Insiders own 7.70% of the company's stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Canaccord Genuity Group raised their target price on shares of Heartflow from $45.00 to $56.00 and gave the company a "buy" rating in a report on Tuesday, September 22nd. Freedom Capital raised shares of Heartflow to a "strong-buy" rating in a report on Tuesday, June 30th. Robert W. Baird set a $45.00 price target on shares of Heartflow in a research report on Friday, August 14th. JPMorgan Chase & Co. raised their price objective on shares of Heartflow from $35.00 to $45.00 and gave the stock an "overweight" rating in a research note on Friday, August 14th. Finally, Benchmark restated a "buy" rating on shares of Heartflow in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Heartflow currently has an average rating of "Moderate Buy" and an average target price of $46.25.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries and provide noninvasive assessments of blood flow and disease.

The company's products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.